March 3, 2026

Managing Drug Interactions between Antiretrovirals and Opportunistic Infections in People with HIV

Key Points

Management of drug interactions enhances treatment safety for patients with HIV and opportunistic infections.
Evidence indicates that risk mitigation strategies can significantly decrease adverse interactions, improving patient outcomes.
Future strategies may involve regimen simplification with newer antiretrovirals to reduce interaction risks effectively.
Comprehensive approaches should address both antiretrovirals and opportunistic infection therapies to enhance overall care.

Abstract

While advancements in care have simplified treatment for these patients, there is still a considerable risk of interactions between antiretrovirals and opportunistic infections, as well as the drugs used to treat them. Future strategies, including newer agents, regimen simplification, and comprehensive management strategies, can further decrease the risk of interactions between antiretrovirals and opportunistic infection agents, as well as further decrease the risk of IRIS.

Bookmark

Cite This Study

Ott et al. (Thu,) studied this question.

synapsesocial.com/papers/69a75ae6c6e9836116a21577 https://doi.org/https://doi.org/10.2174/011570162x419952251030045143

Bookmark